MIRA Pharmaceuticals, Inc. Additional Paid in Capital
MIRA Pharmaceuticals, Inc. (MIRA) had Additional Paid in Capital of $50.10 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-12
- 2026-06-30: Additional Paid in Capital $50.10M.
- 2026-03-31: Additional Paid in Capital $50.08M.
- 2025-12-31: Additional Paid in Capital $49.97M.
- 2025-09-30: Additional Paid in Capital $41.14M.
| Period end | Additional Paid in Capital |
|---|---|
| 2026-06-30 | $50.10M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $50.08M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $49.97M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $41.14M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $33.03M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $32.21M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $31.34M 10-K · filed 2026-03-31 |
| 2024-09-30 | $30.31M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $26.91M 10-Q/A · filed 2024-08-16 |
| 2024-04-24 | $148.70K 10-K · filed 2026-03-31 |
| 2024-03-31 | $26.16M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $25.66M 10-K · filed 2025-03-28 |
| 2023-09-30 | $23.61M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $13.10M 10-Q · filed 2023-09-15 |
| 2022-12-31 | $8.70M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |